PRESCRIBERS |
|
|
Main prescribers: General practitioners |
63.40% |
|
INSURED CONSUMERS |
|
|
% of insured consumers |
1.23% |
|
Median age |
74 years |
|
Max/min ratio of the median age (by district) |
1.07 |
|
Percentage of women |
87.36% |
|
Ratio Preferential scheme/General scheme |
1.21 |
|
Coefficient of variation (2022) |
24.95 |
|
Max/min ratio of % of insured consumers (by district) |
2.30 |
|
CONSUMPTION |
|
|
Annual consumption (DDD) |
57,260,560 |
|
Consumption of DDD (per 100,000 insured persons) |
497,532.87 |
|
% DDD issued outside the insurance (approximate) |
3.28% |
|
Average annual consumption per insured consumer (DDD) |
403.59 |
|
% of insured consumers with > 3 times the average consumption |
4,36% |
|
Coefficient of variation 2013-2015 |
14.66 |
|
Coefficient of variation 2020-2022 |
25.91 |
Trend 2013-2022 |
-1.06% |
|
Trend 2013-2019 |
-0.59% |
|
Trend 2019-2022 |
-2.00% |
DIRECT EXPENDITURE (DDD) |
|
|
Annual expenditure charged to the insurance |
40,657,466€ |
|
Average annual expenditure per insured person |
3.53 € |
|
Average patient share per insured consumer |
6.25% |
|
Max/min ratio of expenditure per insured person (by disctrict) |
3.14 |
|
% “Low-cost” medication |
27.36% |
|
Trend 2013-2022 |
-1.64% |
|
Trend 2019-2022 |
0.34% |
|
On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.
CODES (ATC-5) |
LABELS |
M05BA |
BISPHOSPHONATES |
M05BB |
BISPHOSPHONATES, COMBINATIONS |
M05BX |
OTHER DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.
Click below to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.
![Drugs affecting bone structure and mineralization (2022) Drugs affecting bone structure and mineralization (2022)](/images/INAMI/Graphiques/Osteoporose_2022/resized/Osteoporose_2022-Nomen_140x100.png)
Osteoporose_2022-Occurrence
Osteoporose_2022-Nomen
Osteoporose_2022-BIM
Osteoporose_2022-Cheap
Osteoporose_2022-Trends
Osteoporose_2022-DotPlot
Osteoporose_2022-Redondance
Osteoporose_2022-Carte
Osteoporose_2022-Sexratio
Osteoporose_2022-RegionTrends
Osteoporose_2022-AgeCV
Osteoporose_2022-Funnel
WE ARE INTERESTED IN YOUR OPINION
Do you have any experience in this area ? We listen to you !
Send us an email